We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi-Aventis to Acquire Full Japanese Rights to Acomplia
Sanofi-Aventis to Acquire Full Japanese Rights to Acomplia
April 14, 2006
Sanofi-aventis said it would acquire all Japanese rights to the experimental antiobesity and smoking-cessation drug Acomplia from Fujisawa sanofi-aventis, a joint venture of sanofi-aventis and Japan’s Astellas Pharma.